Depletion-restitution therapy of autoimmune rheumatic diseases. Part 2. Perspectives on bispecific antibodies

One of the most promising approaches to depletion-restitution therapy is the development and use of drugs based on bispecific monoclonal antibodies (bsAbs). Therapeutic bsAbs are genetically engineered biological products (biologics) based on immunoglobulin molecules capable of simultaneously bindin...

Full description

Bibliographic Details

Published in:	Современная ревматология
Main Authors:	A. L. Maslyanskiy, D. A. Dibrov, A. M. Lila, A. V. Torgashina, E. G. Zotkin, M. Yu. Samsonov, G. A. Togizbayev
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2025-06-01
Subjects:	depletion therapy depletion-restitution therapy b-cells plasma cells bispecific antibodies monoclonal antibodies
Online Access:	https://mrj.ima-press.net/mrj/article/view/1769